CD274 and neoplasm: These findings suggest that in addition to the ability of AS101 to increase tumor sensitivity to chemotherapy, tumor PD-L1 downregulation (PD-L1 expression was not tested at that time) might contribute to enhanced antitumor effects by alleviating tumor-induced immune suppression.